Table Of Contents
1 Introduction 21
1.1 Objectives Of The Study 21
1.2 Market Definition 21
1.3 Overview Of North America Antimicrobial Susceptibility Testing Market 21
1.4 Currency And Pricing 22
1.5 Limitation 22
1.6 Markets Covered 23
2 Market Segmentation 25
2.1 Markets Covered 25
2.2 Geographic Scope 26
2.3 Years Considered For The Study 27
2.4 Currency And Pricing 27
2.5 Research Methodology 28
2.6 Primary Interviews With Key Opinion Leaders 31
2.7 The Category Vs Time Grid 32
2.8 DBMR Market Challenge Matrix 33
2.9 Secondary Sources 34
2.10 Assumptions 34
3 Market Overview 35
3.1 Drivers 37
3.1.1 Increase In Number Of Infectious Disease 37
3.1.2 Technological Advancements In Antimicrobial Susceptibility Methods 38
3.1.3 Emergence Of Multidrug Resistance Due To Multiple Drug Use 39
3.1.4 Increased Funding, Research Grants, And Public-Private Investments 40
3.2 Restraints 41
3.2.1 High Cost Of Automated Antimicrobial Susceptibility Testing Systems 41
3.3 Opportunities42
3.3.1 Emerging Markets To Offer Lucrative Opportunities 42
3.3.2 Increase Awareness To Detect And Control Antimicrobial Resistance 43
3.4 Challenges 44
3.4.1 Lack Of Coordination Between Regulatory Bodies, Clinical Laboratories, And Ast Manufacturers 44
4 Executive Summary 45
5 Premium Insights 47
6 North America Antimicrobial Susceptibility Testing Market,
By Product 49
6.1 Overview 50
6.2 Manual 52
6.2.1 Susceptibility Testing Disks 53
6.2.2 Mic Strips 54
6.2.3 Susceptibility Plates 54
6.2.4 Antimicrobial Susceptibility Testing Culture Media 55
6.2.5 Consumables 55
6.3 Automated 56
6.3.1 Susceptibility Plates 57
6.3.2 Automated Instruments 58
6.3.3 Susceptibility Plate Ancillaries 58
7 North America Antimicrobial Susceptibility Testing Market,
By Methods 59
7.1 Overview 60
7.2 Dilution Methods 61
7.3 Disk Diffusion Method 62
7.4 E- Test 63
7.5 Genotypic Methods 65
7.6 Automated Systems 66
8 North America Antimicrobial Susceptibility Testing Market,
By Application 67
8.1 Overview 68
8.2 Clinical Diagnostics 69
8.3 Drug Discovery And Development 70
8.4 Epidemiology 71
8.5 Others 73
9 North America Antimicrobial Susceptibility Testing Market,
By End User 74
9.1 Overview 75
9.2 Hospitals 77
9.3 Pharmaceutical And Biotechnology Companies 79
9.4 Diagnostic Laboratories 80
9.5 Research And Academic Institutes 81
9.6 Contract Research Organizations 82
10 North America Antimicrobial Susceptibility Testing Market,
By Geography 83
10.1 North America 83
10.1.1 U.S. 90
10.1.2 Canada 94
10.1.3 Mexico 98
11 North America Antimicrobial Susceptibility Testing Market,
Company Landscape 102
11.1 Company Share Analysis; North America 102
12 Company Profiles 103
12.1 Biom?rieux Sa Company 103
12.1.1 Overview 103
12.1.2 Revenue Analysis 103
12.1.3 Company Share Analysis 104
12.1.4 Product Portfolio 104
12.1.5 Recent Developments 105
12.2 Thermo Fisher Scientific Inc. 107
12.2.1 Company Overview 107
12.2.2 Revenue Analysis 107
12.2.3 Company Share Analysis 108
12.2.4 Product Portfolio 108
12.2.5 Recent Developments 111
12.3 Bd 112
12.3.1 Company Overview 112
12.3.2 Revenue Analysis 112
12.3.3 Company Share Analysis 113
12.3.4 Product Portfolio 113
12.3.5 Recent Developments 114
12.4 Accelerate Diagnostics, Inc. 116
12.4.1 Company Overview 116
12.4.2 Revenue Analysis 116
12.4.3 Product Portfolio 116
12.4.4 Recent Developments 117
?
12.5 Alifax Holding S.P.A. 118
12.5.1 Company Overview 118
12.5.2 Geographic Presence 118
12.5.3 Product Portfolio 119
12.5.4 Recent Developments 119
12.6 Bio-Rad Laboratories Inc. 120
12.6.1 Company Overview 120
12.6.2 Revenue Analysis 120
12.6.3 Product Portfolio 121
12.6.4 Recent Developments 121
12.7 Bioanalyse Tibbi Malz. San. Ve Tic. Ltd. Sti. 122
12.7.1 Company Overview 122
12.7.2 Product Portfolio 122
12.7.3 Recent Developments 122
12.8 Conda 123
12.8.1 Company Overview 123
12.8.2 Geographic Presence 123
12.8.3 Product Portfolio 124
12.8.4 Recent Developments 125
12.9 Creative Diagnostics 126
12.9.1 Company Overview 126
12.9.2 Geographic Presence 126
12.9.3 Product Portfolio 127
12.9.4 Recent Developments 127
12.10 Genefluidics Inc.128
12.10.1 Company Overview 128
12.10.2 Product Portfolio 128
12.10.3 Recent Developments 128
12.11 Himedia Laboratories 129
12.11.1 Company Overview 129
12.11.2 Geographic al Presence 129
12.11.3 Product Portfolio 130
12.11.4 Recent Developments 131
12.12 Liofilchem Srl. 132
12.12.1 Company Overview 132
12.12.2 Product Portfolio 132
12.12.3 Recent Developments 133
?
12.13 Merck Millipore 134
12.13.1 Company Overview 134
12.13.2 Geographic Presence 134
12.13.3 Product Portfolio 135
12.13.4 Recent Developments 135
12.14 Zhuhai Dl Biotech. Co., Ltd 136
12.14.1 Company Overview 136
12.14.2 Product Portfolio 136
12.14.3 Recent Developments 136
13 Related Reports 137
?